UY33242A - Tratamiento de afecciones alérgicas dermatológicas - Google Patents

Tratamiento de afecciones alérgicas dermatológicas

Info

Publication number
UY33242A
UY33242A UY0001033242A UY33242A UY33242A UY 33242 A UY33242 A UY 33242A UY 0001033242 A UY0001033242 A UY 0001033242A UY 33242 A UY33242 A UY 33242A UY 33242 A UY33242 A UY 33242A
Authority
UY
Uruguay
Prior art keywords
treatment
dermatological allergic
dermatological
allergic affections
affections
Prior art date
Application number
UY0001033242A
Other languages
English (en)
Inventor
Choi-Sledeski Yong Mi
Neil Fitch
Anne Minnich
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY33242A publication Critical patent/UY33242A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describe un tratamiento para afección alérgica dermatológica, que usa un compuesto: como [4-(5-aminometil-2-fluorofenil)piperidin-1-il][7-fluoro-1-(2-metoxietil)-4-trifluorometoxi-1H-indol-3-il]metanona.
UY0001033242A 2010-02-24 2011-02-24 Tratamiento de afecciones alérgicas dermatológicas UY33242A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30765010P 2010-02-24 2010-02-24
FR1060021 2010-12-02

Publications (1)

Publication Number Publication Date
UY33242A true UY33242A (es) 2011-09-30

Family

ID=43901272

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033242A UY33242A (es) 2010-02-24 2011-02-24 Tratamiento de afecciones alérgicas dermatológicas

Country Status (15)

Country Link
US (1) US20120309790A1 (es)
EP (1) EP2538942A1 (es)
JP (1) JP2013520506A (es)
KR (1) KR20130009769A (es)
CN (1) CN102858336A (es)
AR (1) AR080255A1 (es)
AU (1) AU2011220909A1 (es)
BR (1) BR112012020965A2 (es)
CA (1) CA2790946A1 (es)
MX (1) MX2012009523A (es)
RU (1) RU2521357C2 (es)
SG (1) SG183342A1 (es)
TW (1) TW201141478A (es)
UY (1) UY33242A (es)
WO (1) WO2011106334A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998028292A1 (en) * 1996-12-23 1998-07-02 Smithkline Beecham Corporation Novel piperidine containing compounds
GB0012362D0 (en) * 2000-05-22 2000-07-12 Aventis Pharma Ltd Chemical compounds
DOP2005000039A (es) * 2004-03-26 2005-10-31 Aventis Pharma Inc Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
EP2367812B1 (en) * 2008-08-22 2015-09-16 Sanofi [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4trifluoromethoxy-1h-indol-3-yl]methanone as an inhibitor of mast cell tryptase

Also Published As

Publication number Publication date
RU2521357C2 (ru) 2014-06-27
US20120309790A1 (en) 2012-12-06
SG183342A1 (en) 2012-09-27
JP2013520506A (ja) 2013-06-06
AR080255A1 (es) 2012-03-21
WO2011106334A1 (en) 2011-09-01
MX2012009523A (es) 2012-08-31
RU2012140438A (ru) 2014-03-27
BR112012020965A2 (pt) 2016-05-03
CA2790946A1 (en) 2011-09-01
CN102858336A (zh) 2013-01-02
TW201141478A (en) 2011-12-01
EP2538942A1 (en) 2013-01-02
AU2011220909A1 (en) 2012-09-13
KR20130009769A (ko) 2013-01-23

Similar Documents

Publication Publication Date Title
CR20140161A (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
UA110338C2 (en) Chemical compounds
UA111161C2 (uk) Похідна фталазинонкетону, спосіб її одержання та її фармацевтичне застосування
CR20150066A (es) 2,3-benzodiacepinas
CR20140229A (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
MA32937B1 (fr) Composes organiques
CR20120113A (es) (heteroarilmetil)tiohidantoinas sustituidas como drogas anticancer
EA201590583A1 (ru) Способ получения терапевтических наночастиц
CR20130045A (es) Compuestos terapéuticos
EA201390198A1 (ru) Гетероциклическое соединение
CO6430459A2 (es) Derivados de prolina como inhibidores de catepsina
UY34051A (es) Derivados de pirrolotriazinona como inhibidores de pi3k
CR20120641A (es) Compuestos macrocìclicos como inhibidores de quinasa trk
CY1114766T1 (el) Χρηση μπεθανεχολης για αντιμετωπιση ξηροστομιας
MX351464B (es) El uso de un agonista del receptor 8 tipo toll para el tratamiento de enfermedades alérgicas.
EA201200098A1 (ru) Конденсированные имидазолы и содержащие их композиции, предназначенные для лечения паразитарных заболеваний, таких как, например, малярия
UA111075C2 (uk) Триазолопіридинові сполуки як інгібітори кінази рім
GEP201706623B (en) Pyrrolotriazinone derivatives as pi3k inhibitors
GT201400090A (es) 2-tiopirimidinonas
HN2010001920A (es) Dihidropirazolonas sustituidas como inhibidores de hif- propil-4-hidroxilasa
EA201492023A1 (ru) Регуляторы пути комплемента и их применение
UY33888A (es) Derivados de (1,2,4) triazolo [4,3-a) quinoxalina como inhibidores de fosfodiesterasas
EA201270255A1 (ru) 5-фтор-2-оксопиримидин-1(2h)-карбоксилатные производные
BR112013010136A2 (pt) vacina, composição terapêutica e métodos para o tratamento ou inibição de gliblastoma
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20191216